151 related articles for article (PubMed ID: 11911437)
1. Pharmacogenomics and schizophrenia: clinical implications.
Malhotra AK
Pharmacogenomics J; 2001; 1(2):109-14. PubMed ID: 11911437
[No Abstract] [Full Text] [Related]
2. Pharmacogenomics-informed clozapine therapy.
Bousman CA
Lancet Psychiatry; 2023 Mar; 10(3):160-162. PubMed ID: 36804063
[No Abstract] [Full Text] [Related]
3. Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine.
Masellis M; Basile VS; Ozdemir V; Meltzer HY; Macciardi FM; Kennedy JL
Biol Psychiatry; 2000 Feb; 47(3):252-66. PubMed ID: 10682223
[TBL] [Abstract][Full Text] [Related]
4. [Dopamine D4-receptor variants, schizophrenia and clozapine therapy].
Ewald HL; Mors NP; Rosenberg R
Ugeskr Laeger; 1996 Jun; 158(25):3601-3. PubMed ID: 8693618
[TBL] [Abstract][Full Text] [Related]
5. [How do clozapine and co. work? Pharmacologic mechanisms of atypical neuroleptics].
Müller WE
Pharm Unserer Zeit; 2002; 31(6):537-45. PubMed ID: 12481511
[No Abstract] [Full Text] [Related]
6. Genetic variation of 5-HT2A receptor and response to clozapine.
Masellis M; Paterson AD; Badri F; Lieberman JA; Meltzer HY; Cavazzoni P; Kennedy JL
Lancet; 1995 Oct; 346(8982):1108. PubMed ID: 7564821
[No Abstract] [Full Text] [Related]
7. Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine.
Arranz MJ; Collier DA; Munro J; Sham P; Kirov G; Sodhi M; Roberts G; Price J; Kerwin RW
Neurosci Lett; 1996 Oct; 217(2-3):177-8. PubMed ID: 8916101
[TBL] [Abstract][Full Text] [Related]
8. Implementation of pharmacogenetics in a clozapine treatment resistant patient: a case report.
Sangüesa E; Cirujeda C; Concha J; Padilla PP; Ribate MP; García CB
Pharmacogenomics; 2019 Aug; 20(12):871-877. PubMed ID: 31453772
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of dopamine receptor D1 rs4532 polymorphism and susceptibility to antipsychotic treatment response.
de Matos LP; Santana CV; Souza RP
Psychiatry Res; 2015 Sep; 229(1-2):586-8. PubMed ID: 26213377
[TBL] [Abstract][Full Text] [Related]
10. Dopamine2 receptor occupancy and the action of clozapine: does it make a difference to add a neuroleptic?
Meltzer HY
Biol Psychiatry; 1999 Jul; 46(1):144-9. PubMed ID: 10394487
[No Abstract] [Full Text] [Related]
11. Pharmacogenomics in schizophrenia: the quest for individualized therapy.
Basile VS; Masellis M; Potkin SG; Kennedy JL
Hum Mol Genet; 2002 Oct; 11(20):2517-30. PubMed ID: 12351588
[TBL] [Abstract][Full Text] [Related]
12. A weight off the mind: Clozapine and profound weight loss.
Webster A; Ingram L
Aust N Z J Psychiatry; 2013 Dec; 47(12):1212-3. PubMed ID: 23881075
[No Abstract] [Full Text] [Related]
13. Clozapine, GABA(B), and the treatment of resistant schizophrenia.
Daskalakis ZJ; George TP
Clin Pharmacol Ther; 2009 Oct; 86(4):442-6. PubMed ID: 19626000
[No Abstract] [Full Text] [Related]
14. Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.
Dervaux A; Cazali J
J Clin Psychopharmacol; 2007 Oct; 27(5):514-6. PubMed ID: 17873688
[No Abstract] [Full Text] [Related]
15. Pharmacogenetics of antipsychotic treatment in schizophrenia.
Pouget JG; Müller DJ
Methods Mol Biol; 2014; 1175():557-87. PubMed ID: 25150876
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of the clozapine response.
Schumacher J; Schulze TG; Wienker TF; Rietschel M; Nöthen MM
Lancet; 2000 Aug; 356(9228):506-7. PubMed ID: 10981913
[No Abstract] [Full Text] [Related]
17. "Awakening" from schizophrenia: intramolecular polypharmacy and the atypical antipsychotics.
Stahl SM
J Clin Psychiatry; 1997 Sep; 58(9):381-2. PubMed ID: 9378687
[No Abstract] [Full Text] [Related]
18. Clozapine and typical antipsychotics.
Ross DE
Am J Psychiatry; 2004 Oct; 161(10):1925-6. PubMed ID: 15465996
[No Abstract] [Full Text] [Related]
19. Pharmacogenetics in schizophrenia: a review of clozapine studies.
Kohlrausch FB
Braz J Psychiatry; 2013; 35(3):305-17. PubMed ID: 24142094
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update.
Sriretnakumar V; Huang E; Müller DJ
Expert Opin Drug Metab Toxicol; 2015; 11(11):1709-31. PubMed ID: 26364648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
